REFERENCES
1. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia
mechanisms. JCardiovasc Electrophysiol. 2001;12(2):268-272.
2. Antzelevitch C, Di Diego JM. J wave syndromes: What’s new?Trends Cardiovasc Med. 2022;32(6):350-363.
3. Nademanee K, Veerakul G, Chandanamattha P, et al. Prevention of
ventricular fibrillation episodes in Brugada syndrome by catheter
ablation over the anterior right ventricular outflow tract epicardium.Circulation. 2011;123(12):1270-1279.
4. Brugada J, Pappone C, Berruezo A, et al. Brugada Syndrome Phenotype
Elimination by Epicardial Substrate Ablation. Circ Arrhythm
Electrophysiol. 2015;8(6):1373-1381.
5. Pappone C, Brugada J, Vicedomini G, et al. Electrical Substrate
Elimination in 135 Consecutive Patients With Brugada Syndrome.Circ Arrhythm Electrophysiol. 2017;10(5):e005053.
6. Salghetti F, de Asmundis C, Sieira J, et al. Hybrid thoracoscopic
epicardial ablation of right ventricular outflow tract in patients with
Brugada syndrome. Heart Rhythm. 2019;16(6):879-887.
7. Grossi S, Bianchi F, Pintor C, Musumeci G, Gaita F. Transcatheter
ablation in patients with Brugada syndrome. Eur Heart J Suppl.2023;25(Suppl C):C38-c43.
8. Nademanee K, Chung FP, Sacher F, et al. Long-Term Outcomes of Brugada
Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF
Substrate Ongoing Multicenter Registry). Circulation.2023;147(21):1568-1578.
9. Haissaguerre M, Extramiana F, Hocini M, et al. Mapping and ablation
of ventricular fibrillation associated with long-QT and Brugada
syndromes. Circulation. 2003;108(8):925-928.
10. Sunsaneewitayakul B, Yao Y, Thamaree S, Zhang S. Endocardial mapping
and catheter ablation for ventricular fibrillation prevention in Brugada
syndrome. J Cardiovasc Electrophysiol. 2012;23 Suppl 1:S10-S16.
11. Talib AK, Takagi M, Shimane A, et al. Efficacy of Endocardial
Ablation of Drug-Resistant Ventricular Fibrillation in Brugada Syndrome:
Long-Term Outcome. Circ Arrhythm Electrophysiol.2018;11(8):e005631.
12. Kamakura T, Cochet H, Juhoor M, et al. Role of endocardial ablation
in eliminating an epicardial arrhythmogenic substrate in patients with
Brugada syndrome. Heart Rhythm. 2021;18(10):1673-1681.
13. Fish JM, Antzelevitch C. Role of sodium and calcium channel block in
unmasking the Brugada syndrome. Heart Rhythm. 2004;1(2):210-217.
14. Antzelevitch C, Patocskai B. Ajmaline-Induced Slowing of Conduction
in the Right Ventricular Outflow Tract Cannot Account for ST Elevation
in Patients With Type I Brugada ECG. Circ Arrhythm
Electrophysiol. 2017;10(10):e005775.
15. Di Diego JM, Antzelevitch C. Pinacidil-induced electrical
heterogeneity and extrasystolic activity in canine ventricular tissues.
Does activation of ATP-regulated potassium current promote phase 2
reentry? Circulation. 1993;88(3):1177-1189.
16. Litovsky SH, Antzelevitch C. Transient outward current prominent in
canine ventricular epicardium but not endocardium. CircRes.1988;62(1):116-126.
17. Morita H, Zipes DP, Morita ST, Wu J. Differences in
arrhythmogenicity between the canine right ventricular outflow tract and
anteroinferior right ventricle in a model of Brugada syndrome.Heart Rhythm. 2007;4(1):66-74.
18. Antzelevitch C, Yan GX, Ackerman MJ, et al. J-Wave syndromes expert
consensus conference report: Emerging concepts and gaps in knowledge.Heart Rhythm. 2016(13):e295-324.
19. Di Diego JM, Patocskai B, Barajas-Martinez H, et al. Acacetin
suppresses the electrocardiographic and arrhythmic manifestations of the
J wave syndromes. PLoS One. 2020;15(11):e0242747.
20. Zhang P, Tung R, Zhang Z, et al. Characterization of the epicardial
substrate for catheter ablation of Brugada syndrome. Heart
Rhythm. 2016;13(11):2151-2158.
21. Patocskai B, Yoon N, Antzelevitch C. Mechanisms Underlying
Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in
Experimental Models of Brugada Syndrome. JACC: Clinical
Electrophysiology. 2017;3(4):353.
22. Morita H, Zipes DP, Morita ST, Wu J. Temperature modulation of
ventricular arrhythmogenicity in a canine tissue model of Brugada
syndrome. Heart Rhythm. 2007;4(2):188-197.
23. Nademanee K, Haïssaguerre M. Endocardial Ablation Approach for
Brugada Syndrome: An Important First Step or a Quixotic Quest.Circ Arrhythm Electrophysiol. 2018;11(8):e006675.
24. Letsas KP, Vlachos K, Efremidis M, et al. Right ventricular outflow
tract endocardial unipolar substrate mapping: implications in risk
stratification of Brugada syndrome. Rev Cardiovasc Med.2022;23(2):44.
25. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and
other mechanisms of arrhythmogenesis associated with ST segment
elevation. Circulation. 1999;100(15):1660-1666.
26. Morita H, Zipes DP, Wu J. Brugada syndrome: insights of ST
elevation, arrhythmogenicity, and risk stratification from experimental
observations. Heart Rhythm. 2009;6(11 Suppl):S34-S43.